CONMED Corporation to Present at The UBS Global Life Sciences Conference on Wednesday, September 26, 2007
Conmed zu myNews hinzufügen Was ist das?
CONMED Corporation (Nasdaq: CNMD), a medical technology company
specializing in medical devices for surgical and patient monitoring
markets, announced today that the Company will participate in The UBS
Global Life Sciences Conference on Wednesday, September 26, 2007 at
11:30 AM Eastern time. The event will be held in New York at the Grand
Hyatt Hotel.
Mr. Joseph J. Corasanti, President and Chief Executive Officer of
CONMED, will discuss the Company’s business.
The live webcast of CONMED’s presentation will
be available at www.conmed.com in
the Investor Relations - Events Calendar section of the website and will
be available for replay through October 3, 2007.
CONMED Profile
CONMED is a medical technology company with an emphasis on surgical
devices and equipment for minimally invasive procedures and patient
monitoring. The Company’s products serve the
clinical areas of sports medicine-arthroscopy, powered surgical
instruments, electrosurgery, cardiac monitoring disposables, endosurgery
and endoscopic technologies. Surgeons and physicians in a variety of
specialties including orthopedics, general surgery, gynecology,
neurosurgery, and gastroenterology use the Company’s
medical devices. Headquartered in Utica, New York, the Company’s
3,200 employees distribute its products worldwide from several
manufacturing locations.
Forward Looking Information Certain statements made in the presentation may constitute
forward-looking statements. The forward-looking statements are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and relate to the Company’s
performance on a going-forward basis. They will be based upon
management’s expectations and involve risks
and uncertainties which could cause actual results, performance or
trends, to differ materially from those expressed in the forward-looking
statements therein or in previous disclosures. The Company
believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management’s
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct. In
addition to general industry and economic conditions, factors that could
cause actual results to differ materially from those discussed in the
forward-looking statements include, but are not limited to: (i) the
failure of any one or more of management’s
assumptions to prove to be correct; (ii) the risks relating to
forward-looking statements discussed in the Company’s
filings with the Securities and Exchange Commission, including the
Company’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2006 and Quarterly Reports on Form 10-Q;
(iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new
products by the market; (v) the introduction of new products by
competitors and other competitive responses; (vi) the possibility that
any new acquisition (and its integration) or other transaction may
require the Company to reconsider its financial assumptions and
goals/targets; (vii) increasing costs for raw material, transportation,
or litigation; and/or (viii) the Company’s
ability to devise and execute strategies to respond to market conditions.
